Since unbalanced production of pro- and anti-inflammatory adipocytokines in obesity has been implicated in the pathogenesis of NASH [32], we examined serum adipocytokine concentrations and found that EPA treatment significantly increased serum adiponectin concentrations in MC4R-KO mice (Table 1). This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatohepatitis.